“Our work is focused on developing new drug therapies for biodefense-related and emerging viral pathogens. IPA was the bridge between our high throughput siRNA screen and identification of effective drugs that blocked infection in culture and are showing great promise in our animal work. We expect that IPA will also be an important tool when analyzing results of our latest high throughput drug screens.”
– Robert Davey, PhD, Galveston National Laboratory,
University of Texas Medical Branch (UTMB)
See how IPA was used in this publication:
Identification of Novel Cellular Targets for Therapeutic Intervention Against Ebola Virus Infection by siRNA Screening
Drug Development Research 70 : 255–265 (2009) Andrey A. Kolokoltsov, Mohammad F. Saeed, Alexander N. Freiberg, Michael R. Holbrook, and Robert A. Davey.
» Link to Article Synopsis
» Search Publications
|
